Transcriptional Effects of Chronic Akt Activation in the Heart
Open accessThe DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
Akt activation reduces cardiomyocyte death and induces cardiac hypertrophy. To help identify effector mechanisms, gene expression profiles in hearts from transgenic mice with cardiac-specific expression of activated Akt (myr-Akt) were compared with littermate controls. 40 genes were identified as differentially expressed. Quantitative reverse transcription-PCR confirmed qualitative results of transcript profiling for 9 of 10 genes examined, however, there were notable quantitative discrepancies between the quantitative reverse transcription-PCR and microarray data sets. Interestingly Akt induced significant up-regulation of insulin-like growth factor-binding protein-5 (IGFBP-5), which could contribute to its anti-apoptotic effects in the heart. In addition, Akt-mediated down-regulation of peroxisome proliferator-activated receptor (PPAR) gamma coactivator-1 (PGC-1) and PPAR-alpha may shift myocytes toward glycolytic metabolism shown to preserve cardiomyocyte function and survival during transient ischemia. IGFBP-5 transcripts also increased after adenoviral gene transfer of myr-Akt to cultured cardiomyocytes, suggesting that this represents a direct effect of Akt activation. In contrast, substantial induction of growth differentiation factor-8 (GDF-8), a highly conserved inhibitor of skeletal muscle growth, was observed in transgenic hearts but not after acute Akt activation in vitro, suggesting that GDF-8 induction may represent a secondary effect perhaps related to the cardiac hypertrophy seen in these mice. Thus, microarray analysis reveals previously unappreciated Akt regulation of genes that could contribute to the effects of Akt on cardiomyocyte survival, metabolism, and growth.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“AKT phosphorylates and inhibits PGC-1α in response to insulin in liver [68] and activation of AKT causes a reduction in PGC-1α levels in heart [69].”
From PGC-1α in aging and anti-aging interventions (2009) · cites this paper as [69]
In the citing paper
“AKT is a negative regulator of PGC-1α (Figure 3B).”
From PGC-1α in aging and anti-aging interventions (2009) · cites this paper as [69]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new mathematical model for relative quantification in real-time RT-PCR
Pfaffl, M. W. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.9.e45 · Cited by 34,610
Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor
Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J., & Greenberg, M. E. (1999) · Cell · doi:10.1016/s0092-8674(00)80595-4 · Cited by 5,594
Regulation of skeletal muscle mass in mice by a new TGF-p superfamily member
McPherron, A. C., Lawler, A. M., & Lee, S.-J. (1997) · Nature · doi:10.1038/387083a0 · Cited by 4,013
Bustin, S. (2000) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0250169 · Cited by 3,872
Bodine, S. C., Stitt, T. N., Gonzalez, M., Kline, W. O., Stover, G. L., Bauerlein, R., Zlotchenko, E., Scrimgeour, A., Lawrence, J. C., Glass, D. J., et al. (2001) · Nature Cell Biology · doi:10.1038/ncb1101-1014 · Cited by 2,752
Regulation of neuronal survival by the serine-threonine protein kinase Akt
Dudek, H., Datta, S. R., Franke, T. F., Birnbaum, M. J., Yao, R., Cooper, G. M., Segal, R. A., Kaplan, D. R., & Greenberg, M. E. (1997) · Science · doi:10.1126/science.275.5300.661 · Cited by 2,436
Double muscling in cattle due to mutations in the myostatin gene
McPherron, A. C., & Lee, S.-J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.23.12457 · Cited by 2,039
NF-κB activation by tumour necrosis factor requires the Akt serine–threonine kinase
Nidai Ozes, O., Mayo, L. D., Gustin, J. A., Pfeffer, S. R., Pfeffer, L. M., & Donner, D. B. (1999) · Nature · doi:10.1038/43466 · Cited by 1,832
PI3K: Downstream AKTion Blocks Apoptosis
Franke, T. F., Kaplan, D. R., & Cantley, L. C. (1997) · Cell · doi:10.1016/s0092-8674(00)81883-8 · Cited by 1,668
NF-κB is a target of AKT in anti-apoptotic PDGF signalling
Romashkova, J. A., & Makarov, S. S. (1999) · Nature · doi:10.1038/43474 · Cited by 1,517
Cited by
Items 101–200 of 203
Kalliora, C., & Drosatos, K. (2020) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000891 · Cited by 45
Kim, S. J., Roy, R. R., Kim, J. A., Zhong, H., Haddad, F., Baldwin, K. M., & Edgerton, V. R. (2008) · Journal of Applied Physiology · doi:10.1152/japplphysiol.90668.2008 · Cited by 46
IGFBP5 mediates high glucose-induced cardiac fibroblast activation
Song, S. E., Kim, Y., Kim, J., Lee, D. H., Kim, J., & Park, S. (2013) · Journal of Molecular Endocrinology · doi:10.1530/jme-12-0194 · Cited by 43
Li, R., Zheng, W., Pi, R., Gao, J., Zhang, H., Wang, P., Le, K., & Liu, P. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.06.017 · Cited by 45
Kemper, M. F., Stirone, C., Krause, D. N., Duckles, S. P., & Procaccio, V. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.11.009 · Cited by 42
Ojaimi, C., Li, W., Kinugawa, S., Post, H., Csiszar, A., Pacher, P., Kaley, G., & Hintze, T. H. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00170.2005 · Cited by 42
Erythropoietin and Treatment of Non-anemic Conditions—Cardiovascular Protection
Fliser, D., & Haller, H. G. (2007) · Seminars in Hematology · doi:10.1053/j.seminhematol.2007.04.008 · Cited by 40
Chen, C., Xu, Y., & Song, Y. (2013) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-013-1855-8 · Cited by 39
Stover, J. D., & Nagatomi, J. (2007) · Annals of Biomedical Engineering · doi:10.1007/s10439-007-9331-9 · Cited by 41
Are transgenic mice the ‘alkahest’ to understanding myocardial hypertrophy and failure?
Cook, S. A., Clerk, A., & Sugden, P. H. (2008) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2008.11.005 · Cited by 41
Self-citationBreitbart, A., Scharf, G. M., Duncker, D., Widera, C., Gottlieb, J., Vogel, A., Schmidt, S., Brandes, G., Heuft, H., Lichtinghagen, R., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080454 · Cited by 40
Mechanisms of Disease: erythropoietin—an old hormone with a new mission?
Fliser, D., Bahlmann, F. H., deGroot, K., & Haller, H. G. (2006) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio0609 · Cited by 37
Akt signaling pathway in pacing-induced heart failure
Ananthakrishnan, R., Moe, G. W. P. L., Goldenthal, M. J., & Mar�n-Garc�a, J. (2005) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-005-3699-3 · Cited by 34
Heart mitochondria signaling pathways: appraisal of an emerging field
Mar�n-Garc�a, J., & Goldenthal, M. J. (2004) · Journal of Molecular Medicine · doi:10.1007/s00109-004-0567-7 · Cited by 35
Lee, S.-Y., Ku, H.-C., Kuo, Y., Chiu, H.-L., & Su, M. (2015) · Journal of Biomedical Science · doi:10.1186/s12929-015-0125-3 · Cited by 33
Myostatin signaling is up-regulated in female patients with advanced heart failure
Ishida, J., Konishi, M., Saitoh, M., Anker, M. S., Anker, S. D., & Springer, J. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.03.153 · Cited by 32
DNA Microarray Analysis for Human Congenital Heart Disease
SHARMA, H. S., Peters, T. H. F., Moorhouse, M. J., van der Spek, P. J., & Bogers, A. J. J. C. (2006) · Cell Biochemistry and Biophysics · doi:10.1385/cbb:44:1:001 · Cited by 33
Tiwari, G., Sakaue, H., Pollack, J. R., & Roth, R. A. (2003) · PubMed · Cited by 36
Planavila, A., Alegret, M., Sánchez, R. M., Rodríguez‐Calvo, R., Laguna, J. C., & Vázquez‐Carrera, M. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.01.015 · Cited by 34
Peroxisome proliferator-activated receptors ligands and ischemia-reperfusion injury
Paola, R. D., & Cuzzocrea, S. (2007) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-007-0141-2 · Cited by 36
A small molecule activator of AKT does not reduce ischemic injury of the rat heart
Moreira, J. M. A., Wohlwend, M., Alves, M. N. M., Wisløff, U., & Bye, A. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0444-x · Cited by 29
Cannavò, A., Rengo, G., Liccardo, D., Pironti, G., Scimia, M. C., Scudiero, L., de Lucia, C., Ferrone, M. L., Leosco, D., Zambrano, N., et al. (2013) · APOPTOSIS · doi:10.1007/s10495-013-0876-9 · Cited by 29
Mahmoudabady, M., Mathieu, M., Dewachter, L., Hadad, I., Ray, L., Jespers, P., Brimioulle, S., Naeije, R., & Entee, K. M. (2008) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2008.05.003 · Cited by 29
Harmancey, R., Haight, D. L., Watts, K. A., & Taegtmeyer, H. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.673988 · Cited by 31
Zhang, Y., Wang, D., Li, M., Wei, X., Liu, S., Zhao, M., Liu, C., Wang, X., Jiang, X., Li, X., et al. (2018) · Journal of Proteome Research · doi:10.1021/acs.jproteome.8b00158 · Cited by 35
Wide-range transcriptional modulating effect of ntrR under microaerobiosis in Sinorhizobium meliloti
Puskás, L. G., Nagy, Z. B., Kelemen, J. Z., Rüberg, S., Bodogai, M., Becker, A., & Dusha, I. (2004) · Molecular Genetics and Genomics · doi:10.1007/s00438-004-1051-3 · Cited by 28
Targeting survival signaling in heart failure
Morissette, M. R., & Rosenzweig, A. (2005) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2005.01.004 · Cited by 29
Self-citationMiki, Y., Suzuki, T., Nagasaki, S., Hata, S., Akahira, J., & Sasano, H. (2009) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2009.01.010 · Cited by 32
Arsenault, M., Zendaoui, A., Roussel, É., Drolet, M., Dhahri, W., Grenier, A., Gascon, S., Sarrhini, O., Rousseau, J. A., Lecomte, R., et al. (2013) · Circulation Heart Failure · doi:10.1161/circheartfailure.112.000045 · Cited by 26
Wallace, T. A., VonDerLinden, D., He, K., Frank, S. J., & Sayeski, P. P. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00085.2004 · Cited by 26
Essop, M. F., Chan, W. Y., & Taegtmeyer, H. (2007) · FEBS Journal · doi:10.1111/j.1742-4658.2007.06051.x · Cited by 25
Lu, S., Nie, J., Luan, Q., Feng, Q., Xiao, Q., Chang, Z., Shan, C., Heß, D., Hemmings, B. A., & Yang, Z. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019251 · Cited by 24
Akt signaling as a mediator of cardiac adaptation to low birth weight
Wang, K. C. W., Botting, K. J., Zhang, S., McMillen, I. C., Brooks, D. A., & Morrison, J. L. (2017) · Journal of Endocrinology · doi:10.1530/joe-17-0039 · Cited by 23
Yoshida, E., Atkinson, T. G., & Chakravarthy, B. (2004) · Molecular Brain Research · doi:10.1016/j.molbrainres.2004.08.023 · Cited by 23
Karlowatz, R.-J., Scharhag, J., Rahnenführer, J., Schneider, U., Jakob, E., Kindermann, W., & Zang, K. D. (2009) · British Journal of Sports Medicine · doi:10.1136/bjsm.2008.050567 · Cited by 24
Peroxisome Proliferator-Activated Receptor ?? and Hypertensive Heart Disease
Goikoetxea, M. J., Beaumont, J., & ez, J. D. (2004) · Drugs · doi:10.2165/00003495-200464002-00003 · Cited by 22
嵩原, 由., Tsuchida, K., Nakatani, M., Murakami, T., Kurisaki, A., Hashimoto, O., Ohuchi, H., Kurose, H., Mori, K. J., Kagami, S., et al. (2007) · The Journal of Medical Investigation · doi:10.2152/jmi.54.276 · Cited by 24
Buyandelger, B., Mansfield, C. A., Sawa Kostin, D., Choi, O., Roberts, A. M., Ware, J. S., Mazzarotto, F., Pesce, F., Buchan, R. J., Isaacson, R. L., et al. (2015) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.113.000690 · Cited by 19
Transcriptional changes following restoration of SERCA2a levels in failing rat hearts
del Monte, F., Dalal, R., Tabchy, A. B., Couget, J. A., Bloch, K. D., Peterson, R. T., & Hajjar, R. J. (2004) · The FASEB Journal · doi:10.1096/fj.04-1714fje · Cited by 18
Atorvastatin inhibits GSK-3β phosphorylation by cardiac hypertrophic stimuli
Planavila, A., Rodríguez‐Calvo, R., Palomer, X., Coll, T., Sánchez, R. M., Merlos, M., Laguna, J. C., & Vázquez‐Carrera, M. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2007.10.009 · Cited by 21
Myostatin Regulates Tissue Potency and Cardiac Calcium-Handling Proteins
Jackson, M. F., Li, N., & Rodgers, B. D. (2014) · Endocrinology · doi:10.1210/en.2013-2014 · Cited by 18
Yeh, S., Zambrano, C. M., Koch, W. J., & Purcell, N. H. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.809913 · Cited by 18
Dai, J., Matsui, T., Abel, E. D., Dedhar, S., Gerszten, R. E., Seidman, C. E., Seidman, J. G., & Rosenzweig, A. (2013) · Circulation Heart Failure · doi:10.1161/circheartfailure.113.000649 · Cited by 19
Self-citationMisra, U. K., & Pizzo, S. V. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20233 · Cited by 17
RetractedE2F-1 Regulates the Expression of a Subset of Target Genes during Skeletal Myoblast Hypertrophy
Hlaing, M., Spitz, P., Padmanabhan, K., Cabezas, B., Barker, C. S., & Bernstein, H. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408391200 · Cited by 17
Hartil, K., & CHARRON, M. (2005) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2005.07.005 · Cited by 17
Yousefzadeh, N., Jeddi, S., Ghiasi, R., & Alipour, M. R. (2017) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-017-3089-7 · Cited by 16
Functional and metabolic adaptation in uraemic cardiomyopathy
Smith, K., Semple, D., Aksentijević, D., Bhandari, S., & Seymour, A.-M. L. (2010) · Frontiers in Bioscience-Elite · doi:10.2741/e208 · Cited by 16
Gruson, D., Ginion, A., Lause, P., Ketelslegers, J., Thissen, J., & Bertrand, L. (2012) · Peptides · doi:10.1016/j.peptides.2011.12.017 · Cited by 15
Stearoyl-CoA Desaturase Regulates Angiogenesis and Energy Metabolism in Ischemic Cardiomyocytes
Gan, A., Tracz‐Gaszewska, Z., Ellert‐Miklaszewska, A., Navrulin, V. O., Ntambi, J. M., & Dobrzyń, P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810459 · Cited by 14
Jiang, W. G., Davies, G., Kynaston, H., MASON, M. D., & Fodstad, Ø. (2006) · International Journal of Molecular Medicine · doi:10.3892/ijmm.18.6.1169 · Cited by 14
Siepe, M., Golsong, P., Poppe, A., Blumenthal, B., von Wattenwyl, R., Heilmann, C., Förster, K., Schlensak, C., & Beyersdorf, F. (2010) · Tissue Engineering Part A · doi:10.1089/ten.tea.2009.0721 · Cited by 12
Fas-associated death-domain protein inhibits TNF-α mediated NF-κB activation in cardiomyocytes
Chao, W., Shen, Y., Li, L., Zhao, H., Meiler, S. E. L., Cook, S. A., & Rosenzweig, A. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01216.2004 · Cited by 14
Self-citationMu, X., Qi, W., Liu, Y., Zhou, J., Li, Y., Rong, X., & Lu, L. (2017) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-017-3010-4 · Cited by 11
Hurtado-de-Mendoza, D., Loaiza‐Bonilla, A., Bonilla-Reyes, P. A., & Alcorta, R. (2017) · Cureus · doi:10.7759/cureus.1258 · Cited by 10
Kostyunina, D. S., Ivanova, A. D., & Smirnova, О. V. (2018) · Human Physiology · doi:10.1134/s0362119718010127 · Cited by 13
Rice, K. M., Desai, D. H., Kakarla, S. K., Katta, A., Preston, D. L., Wehner, P. S., & Blough, E. R. (2006) · Cardiovascular Diabetology · doi:10.1186/1475-2840-5-18 · Cited by 9
Through Thick and Thin: A Circulating Growth Factor Inhibits Age-Related Cardiac Hypertrophy
McPherron, A. C. (2013) · Circulation Research · doi:10.1161/circresaha.113.302239 · Cited by 10
Xu, J., Gao, M., Fan, S., Meng, Q., Goldberg, I. D., Abounader, R., Ressom, H. W., Laterra, J., & Rosen, E. M. (2006) · Oncogene · doi:10.1038/sj.onc.1210088 · Cited by 10
Gene expression profiling in experimental models of cardiac load
Rysä, J. (2008) · Cited by 8
The Prominin-1-Derived Peptide Improves Cardiac Function Following Ischemia
Adini, A., Adini, I., Grad, E., Tal, Y., Danenberg, H. D., Kang, P. M., Matthews, B. D., & D’Amato, R. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105169 · Cited by 6
Siddiqui, A. J., Fischer, H., Widegren, U., Grinnemo, K., Hao, X., Månsson‐Broberg, A., Sylvén, C., & Gustafsson, T. P. (2010) · Coronary Artery Disease · doi:10.1097/mca.0b013e3283349cbb · Cited by 6
Dioxygen and Metabolism; Dangerous Liaisons in Cardiac Function and Disease
Angelini, A., Pi, X., & Xie, L. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.01044 · Cited by 6
Gao, Q., Ma, E., Chen, J., Zhao, Q., He, J., Peng, J., Zhu, W., Ren, D., & Wo, D. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e12099 · Cited by 6
Sharifi, A. M., & Mottaghi, S. (2012) · Medical Hypotheses · doi:10.1016/j.mehy.2011.12.021 · Cited by 5
Cyclin D2 is a critical mediator of exercise-induced cardiac hypertrophy
Luckey, S. W., Haines, C. D., Konhilas, J. P., Luczak, E. D., Messmer-Kratzsch, A., & Leinwand, L. A. (2017) · Experimental Biology and Medicine · doi:10.1177/1535370217731503 · Cited by 5
Cardiac Lipid Metabolism: Cells, Metabolites, and Rhythms
Goldberg, I. J., Young, M. E., Schulze, P. C., & Drosatos, K. (2026) · Circulation Research · doi:10.1161/circresaha.126.327471 · Cited by 4
Heart Mitochondria: A Receiver and Integrator of Signals
Marín-García, J. (2011) · Springer eBooks · doi:10.1007/978-1-4419-9461-5_8 · Cited by 3
Post-Genomics Cardiovascular Signaling Pathways
Marín-García, J. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-404599-6.00003-2 · Cited by 6
He, Y., Sun, F., Song, C., Liu, Y., Wang, R., Wang, Y., Sun, X., Juan, Z., & Wang, Y. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114242 · Cited by 3
Vértes, Z., Lengyel, F., Oszter, A., Környei, J., Sümegi, B., & Vértes, M. (2004) · Steroids · doi:10.1016/j.steroids.2004.02.001 · Cited by 3
CDK Inhibitors as Anticancer Agents: Perspectives for the Future
Sridhar, J., Rosen, E. M., Pestell, R. G., & Pattabiraman, N. (2006) · Enzyme inhibitors series/CRC enzyme inhibitors series · doi:10.1201/9781420005400.ch18 · Cited by 5
Cardiovascular Signaling Pathways
Marín-García, J. (2007) · Elsevier eBooks · doi:10.1016/b978-012373698-7/50005-x · Cited by 3
A thermal view of the arterial wall after coronary angioplasty
Diamantopoulos, L. N., Liu, X., & Scheerder, I. D. (2003) · Heart · doi:10.1136/heart.89.6.604 · Cited by 2
Improving Energy Metabolism in the Postischemic Heart-The Story of GIK
Taegtmeyer, H. (2003) · Seminars in Cardiothoracic and Vascular Anesthesia · doi:10.1177/108925320300700113 · Cited by 1
Zhu, W. (2010) · ScholarlyCommons (University of Pennsylvania) · Cited by 1
Marín-García, J. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-147-9_7 · Cited by 1
New directions in cardiac stem cell therapy: An update for clinicians
Singh, S., Kashif, M., Bhambi, N., Makkar, R. R., & Forrester, J. S. (2012) · World Journal of Cardiovascular Diseases · doi:10.4236/wjcd.2012.23032 · Cited by 1
Alterations in Cardiac Metabolism
Peterson, L. R., Schilling, J. D., & Taegtmeyer, H. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5895-3.10020-8 · Cited by 1
Cell Cycle Regulation in Cardiomyocytes
Kartha, C. C. (2021) · Springer eBooks · doi:10.1007/978-3-030-85536-9_3 · Cited by 1
Baldavira, C. M. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2017.tde-28072017-134103 · Cited by 2
Baán, J. A. (2015) · SZTE Repository of Dissertations (University of Szeged) · doi:10.14232/phd.2587
Feasibility of allogeneic stem cells for heart regeneration
Balkan, W., Suncion, V. Y., Telukuntla, K. S., & Hare, J. M. (2014) · Elsevier eBooks · doi:10.1533/9780857096708.2.207
Towards an understanding of protein kinase B (PKB/Akt) function in mouse development
Yang, Z. (2004) · edoc (University of Basel) · doi:10.5451/unibas-003352888
Modulation of growth factors and cell cycle regulatory molecules in experimental cardiomyopathy
Abady, M. M., Naeije, R., & Entee, K. M. (2009)
Genomic stratification in patients with heart failure
Bullard, T. A., Aguilar, F., Hall, J. L., & Blaxall, B. C. (2001) · Cambridge University Press eBooks · doi:10.1017/cbo9780511545849.006
Heart Mitochondria: Receivers and Transmitters of Signals
Marín-García, J. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4599-9_8
Sweeney, T. E. (2010) · DukeSpace (Duke University)
Zhang, J. (2003) · ThinkIR: The University of Louisville's Institutional Repository (University of Louisville) · doi:10.18297/etd/1635
Progress in New Markers for Diabetes Inflammation
Pugia, M. J. (2015) · Springer eBooks · doi:10.1007/978-3-319-21927-1_11
Matsui, T., & Rosenzweig, A. (2005)
Self-citationTissue Repair and Cancer Control through PPARs and Their Coregulators
Michalik, L., & Wahli, W. (2008) · WORLD SCIENTIFIC eBooks · doi:10.1142/9789812819178_0013
Xu, E. (2012) · Corpus Université Laval (Université Laval)
PHLPP2 Negatively Regulates Phenylephrine (PE)- induced Cardiac Hypertrophy
Yeh, S. (2017) · eScholarship (California Digital Library)
Regulation of skeletal muscle mitochondrial biogenesis by GSK-3β
Frank, T. W. (2020) · Research Publications (Maastricht University) · doi:10.26481/dis.20200403wt
Myostatin Expression in the Heart is Temporally and Regionally Distinct
Savinova, I. (2021) · The Atrium (University of Guelph)
Force, T. L., & Molkentin, J. D. (2007) · Humana Press eBooks · doi:10.1007/978-1-59259-963-9_17
Heart Mitochondria Signaling Pathways
Marı́n-Garcı́a, J. (2005) · Springer eBooks · doi:10.1007/0-387-25575-3_10
Dry, J. R., Pavey, S. J., Pratilas, C. A., Harbron, C. G., Runswick, S. K., Hodgson, D., Chresta, C. M., McCormack, R., Byrne, N., Cockerill, M. J., et al. (2023) · doi:10.1158/0008-5472.22386764.v1
Levocarnitine improves cardiac energy metabolic remodeling in myocarditis mice
Yang, S., Li, X., Lu, Z., Xu, X., Guo, Z., & He, B. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1706936
Metadata
- Authors
- Cook, S. A., Matsui, T., Li, L., & Rosenzweig, A.
- Affiliations
- Harvard University (US)
- Corresponding author
- Rosenzweig, Anthony
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2002-06
- Volume
- 277
- Issue
- 25
- Pages
- 22528-22533
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2014333801
- Cited by
- 199
- References
- 45
- Citations by year
- 2026: 2 · 2025: 2 · 2023: 3 · 2022: 3 · 2021: 2 · 2020: 2 · 2019: 1 · 2018: 3 · 2017: 10 · 2015: 10 · 2014: 6 · 2013: 12 · 2012: 8
- FWCI
- 6.86
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6719 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- National University of Singapore (submittedVersion)
- Funders
- Wellcome Trust
- National Institutes of Health
- National Heart, Lung, and Blood Institute (HL61557, HL-59521, R01HL061557, HL04250, R01HL059521, K08HL004250)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Keywords
- Akt activation, cardiomyocyte survival, cardiac hypertrophy, IGFBP-5, PGC-1, PPARα, glycolytic metabolism, myostatin, cardiomyocyte apoptosis, myocardial ischemia
- MeSH terms
- Adenoviridae, Animals, Cell Division, Enzyme Activation, Gene Expression Regulation, Heart, Mice, Inbred C57BL, Myocardium, Proto-Oncogene Proteins, RNA, Messenger, Temperature, Transcription Factors, Transcription, Genetic, Immunoblotting, Transforming Growth Factor beta, Protein Serine-Threonine Kinases, RNA, Complementary, DNA, Complementary, Receptors, Cytoplasmic and Nuclear, Insulin-Like Growth Factor Binding Protein 5, Reverse Transcriptase Polymerase Chain Reaction, Oligonucleotide Array Sequence Analysis, Proto-Oncogene Proteins c-akt, Mice, Myostatin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.